Royal London Asset Management LTD Abiomed Inc Transaction History

Royal London Asset Management LTD

$39.4 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$242.49 - $301.46 $269,163 - $334,620	-1,110 Reduced 6.91%	14,950 $3.68 Million
Q1 2022 May 13, 2022	BUY	$277.25 - $366.29 $84,284 - $111,352	304 Added 1.93%	16,060 $5.32 Million
Q4 2021 Oct 18, 2022	SELL	$300.63 - $371.35 $172,862 - $213,526	-575 Reduced 3.52%	15,756 $5.66 Million
Q4 2021 Jan 18, 2022	SELL	$300.63 - $371.35 $172,862 - $213,526	-575 Reduced 3.52%	15,756 $5.66 Million
Q3 2021 Oct 18, 2022	BUY	$310.19 - $376.2 $134,002 - $162,518	432 Added 2.72%	16,331 $5.32 Million
Q3 2021 Nov 02, 2021	BUY	$310.19 - $376.2 $134,002 - $162,518	432 Added 2.72%	16,331 $5.32 Million
Q2 2021 Oct 18, 2022	SELL	$262.71 - $351.17 $42,296 - $56,538	-161 Reduced 1.0%	15,899 $4.96 Million
Q1 2021 Oct 17, 2022	SELL	$285.92 - $355.13 $46,033 - $57,175	-161 Reduced 1.0%	15,899 $5.07 Million
Q1 2021 Apr 13, 2021	BUY	$285.92 - $355.13 $139,243 - $172,948	487 Added 3.16%	15,899 $5.07 Million
Q4 2020 Jan 29, 2021	SELL	$251.88 - $324.2 $203,015 - $261,305	-806 Reduced 4.97%	15,412 $5 Million
Q3 2020 Nov 04, 2020	SELL	$255.22 - $317.0 $8,167 - $10,144	-32 Reduced 0.2%	16,218 $4.42 Million
Q2 2020 Jul 31, 2020	SELL	$141.4 - $257.09 $98,414 - $178,934	-696 Reduced 4.11%	16,250 $3.9 Million
Q3 2019 Nov 12, 2019	BUY	$175.89 - $279.23 $2.98 Million - $4.73 Million	16,946 New	16,946 $3.02 Million
Q2 2019 Jul 31, 2019	SELL	$250.96 - $284.94 $4.38 Million - $4.98 Million	-17,468 Closed	0 $0
Q4 2018 Jan 29, 2019	BUY	$281.08 - $444.25 $378,333 - $597,960	1,346 Added 8.35%	17,468 $5.56 Million
Q3 2018 Nov 08, 2018	BUY	$354.53 - $449.75 $5.72 Million - $7.25 Million	16,122 New	16,122 $0

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal London Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Royal London Asset Management LTD with notifications on news.

Account